Disease: Idiopathic diffuse interstitial fibrosis
- ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia
- A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema
- A Rare Lung Malignancy in a Case of Systemic Sclerosis
- A retrospective study of combination therapy with glucocorticoids and pirfenidone for PD-1 inhibitor-related immune pneumonitis
- A study on the prevalence and prognosis of progressive pulmonary fibrosis: A retrospective observational study
- Acute Interstitial Pneumonia
- Ambient Ultrafine Particulate Matter and Clinical Outcomes in Fibrotic Interstitial Lung Disease
- An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis
- An Adult Case of Idiopathic Pulmonary Hemosiderosis Associated with Pulmonary Fibrosis and Emphysematous Change
- Animal models of acute exacerbation of pulmonary fibrosis
- Antifibrotic therapy in progressive pulmonary fibrosis: a review of recent advances
- Association between Parenchymal B-Cell Follicles and CT-Proven Enlarged Mediastinal Lymph Nodes in Patients with Pulmonary Fibrosis
- Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis
- Automated airway quantification associates with mortality in idiopathic pulmonary fibrosis
- Beyond the Lungs: O2 Supplementation Improves Cerebral Oxygenation and Fatigue during Exercise in Interstitial Lung Disease
- Case report: A case of acute exacerbation of interstitial pneumonia associated with TAFRO syndrome
- Case Report: Idiopathic pleuroparenchymal fibroelastosis
- Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy
- Compare three diagnostic criteria of progressive pulmonary fibrosis
- Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals
- Considerations for Perioperative Management of Patients with Complicated Respiratory Dysfunction
- Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD
- Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
- Diagnostic finding on high-resolution computed tomography (HRCT) predicts a good response to pirfenidone in patients with idiopathic pulmonary fibrosis
- Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment
- Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
- Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies
- Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis
- Evaluating Tissue Heterogeneity in the Radiologically Normal-Appearing Tissue in IPF Compared to Healthy Controls
- Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease
- FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study
- Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease
- Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease
- Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis
- Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review
- High antinuclear antibody titer is associated with increased mortality risk in patients with idiopathic pulmonary fibrosis
- High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis
- High-Resolution CT Scan Fibrotic Patterns in Stage 4 Pulmonary Sarcoidosis: Impact on Pulmonary Function and Survival
- Histopathological aspects of usual interstitial pneumonia in patients with systemic connective tissue diseases
- Histopathological findings in lung biopsies with usual interstitial pneumonia: Definition of a new classification score for histological fibrotic stages
- Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data
- Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of <em>TDO2</em> as a potential therapeutic target
- Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
- Idiopathic Pulmonary Fibrosis
- Idiopathic Pulmonary Fibrosis Comorbid With Mediastinal Small Cell Carcinoma: A Clinical Dilemma
- ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases
- Imaging Features of Idiopathic Interstitial Lung Diseases
- Imaging of pulmonary fibrosis in children: A review, with proposed diagnostic criteria
- Impact of concomitant gastroesophageal reflux disease symptomology on prognosis and pulmonary function of chronic hypersensitivity pneumonitis
- Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohort
- Increased expiratory flows identify early interstitial lung disease
- Initial results with [<sup>18</sup>F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis
- Interstitial Lung Disease
- Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
- Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia
- Lung function trajectories in patients with idiopathic pulmonary fibrosis
- Lung Magnetic Resonance Imaging for Prediction of Progression in Patients With Nonidiopathic Pulmonary Fibrosis Interstitial Lung Disease: A Pilot Study
- Mechanisms and management of cough in interstitial lung disease
- Mendelian randomization analysis suggests no causal influence of gastroesophageal reflux disease on the susceptibility and prognosis of idiopathic pulmonary fibrosis
- Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial
- Mortality surrogates in combined pulmonary fibrosis and emphysema
- Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role
- Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients
- Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy
- Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
- Novel 3D-based deep learning for classification of acute exacerbation of idiopathic pulmonary fibrosis using high-resolution CT
- Optimisation of the air fraction correction for lung PET/CT: addressing resolution mismatch
- Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis
- Patient-Friendly Summary of the ACR Appropriateness Criteria: Diffuse Lung Disease
- Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant
- Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease
- Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
- Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy
- Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study
- Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease
- Progressive pulmonary fibrosis in myositis-specific antibody-positive interstitial pneumonia: a retrospective cohort study
- Progressive pulmonary fibrosis: where are we now?
- Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats
- Role of Multidisciplinary Team Meetings in the Diagnosis and Management of Diffuse Parenchymal Lung Diseases in a Tertiary Care Hospital
- Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
- Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
- Survival and Lung Function Changes in Hypersensitivity Pneumonitis According to Radiological Phenotypes Compared With Idiopathic Pulmonary Fibrosis
- Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired D<sub>LCO</sub>
- Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
- The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study
- The concept of interstitial pneumonia with autoimmune features (IPAF)
- The efficacy and safety of modified transbronchial cryobiopsy in the diagnosis of interstitial lung disease
- The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
- The interplay of physical and cognitive function in rehabilitation of interstitial lung disease patients: a narrative review
- The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis
- The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
- Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease
- Transbronchial lung cryobiopsy in interstitial lung diseases
- Ultrasound evaluation of diaphragmatic function in patients with idiopathic pulmonary fibrosis: a retrospective observational study
- Unexpected diffuse lung lesions in a patient with pulmonary alveolar proteinosis: A case report
- Up-regulation by overexpression of c-MET in fibroblastic foci of usual interstitial pneumonia
- Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases
- Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis